Stason Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, manufacture, importation/exportation, licensing, and marketing of generic and branded drug products in the United States. It primarily focuses on developing oncology drugs and supportive products for the treatment of side effects related to cancer therapy; and drugs for the treatment of cardiovascular, central nervous system, autoimmune, dermatology, and endocrine disorders. The company also offers contract manufacturing services for high containment and non-high containment products in solid and semi-solid forms, including immediate and delayed release tablets and capsules, fast disintegrating tablets, creams, and lotions to other pharmaceutical companies. It licenses and distributes its products through a network of strategic alliances and distributors in North America and internationally.